On March 31, the House Energy and Commerce Subcommittee on Commerce, Trade, and Consumer Protection is holding a hearing on H.R. 1706, the "Protecting Consumer Access to Generic Drugs Act of 2009," which would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.